Rebecca Kelly Slaughter (Susan Walsh/AP Images)
May 31, 2022 02:14 PM EDTUpdated 04:27 PM
Pharma
Law

Phar­ma merg­ers: FTC and DOJ to ex­plore new ways of en­forc­ing an­titrust laws

Zachary Brennan

Senior Editor

Just when the phar­ma in­dus­try thought to­day’s $3 bil­lion GSK buy­out might kick off M&A sea­son, the De­part­ment of Jus­tice and the Fed­er­al Trade …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times